← SynDRA
CARAMIPHEN
SynDRA canonical compound SYN0002771 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | CHRM1 | CHRM2 |
|---|
| Mechanism of action | cholinergic receptor antagonist |
|---|
| Indication | Parkinson's Disease |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- CHRM1
- CHRM2
- Chrm1
- Chrm2
- PRCP
- SIGMAR1
- Slc6a3
Mechanisms of action (all sources)
- cholinergic receptor antagonist
- CHRM2 INHIBITOR
- CHRM1 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALDH1A1
- ALOX15B
- ATAD5
- CBX1
- EHMT2
- GBA1
- GNAS
- HDAC6
- POLB
- TARDBP
- TDP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ACM1
- ACM4
- ACM5
- CP2D6
- GRK2
- RGS4
Cross-references
Synonyms
- caramiphen edisilate
- caramiphen hydrochloride
- caraminphen
- caramiphen HCl
- caramiphen edisylate
- Caramiphene
- Caramifeno
- CARAMIPEN
- Parpanil
- Pentaphen (pharmaceutical)
- Caramiphen [INN:BAN]
- Caramiphenum [INN-Latin]
- Caramiphene [INN-French]
- UNII-97J7NP0XJY
- Caramifenio [INN-Spanish]
- EINECS 201-013-6
- BRN 2144901
- 97J7NP0XJY
- CYCLOPENTANECARBOXYLIC ACID, 1-PHENYL-, 2-(DIETHYLAMINO)ETHYL ESTER
- CHEMBL61946
- 1-Phenylcyclopentanecarboxylic acid 2-(diethylamino)ethyl ester
- 2-Diethylaminoethyl 1-phenylcyclopentancarboxylat
- 2-(Diethylamino)ethyl 1-phenylcyclopentanecarboxylate
- 2-Diethylaminoethyl 1-phenylcyclopentane-1-carboxylate
- 2-(diethylamino)ethyl 1-phenylcyclopentane-1-carboxylate
- Caramiphenum
- RefChem:918009
- DTXCID802729
- Caramifenio
- MLS000532799
- SMR000140237
- diethylaminoethyl 1-phenylcyclopentane-1-carboxylate
- Caramiphen (free base)
- CARAMIPHEN [MI]
- CARAMIPHEN [INN]
- CARAMIPHEN [VANDF]
- CARAMIPHEN [WHO-DD]
- Pentoxyverine impurity B CRS
Look up CARAMIPHEN in the interactive SynDRA portal →